"According to the latest report published by Data Bridge Market Research, the Nucleic Acid-Based Drugs Market Data Bridge Market Research analyzes that the global nucleic acid-based drugs market, which was USD 32.05 million in 2022, is likely to reach USD 135.97 million by 2030 and is expected to undergo a CAGR of 19.80% during the forecast period.  The supreme Nucleic Acid-Based...

The global Synthetic Biology Market was valued at USD 18.9 billion in 2025 and is projected to grow from USD 22.1 billion in 2026 to USD 69.2 billion by 2033, registering a robust CAGR of 17.7% from 2026 to 2033. The market is witnessing significant expansion as advances in genetic engineering, genome editing, and biological system design continue to unlock new opportunities across...

The CAR-T Cell Therapy Market is experiencing remarkable growth as advanced immunotherapy solutions continue to transform cancer treatment worldwide. Chimeric Antigen Receptor T-cell therapy has emerged as one of the most innovative approaches in oncology, offering personalized treatment options for patients with certain blood cancers. Rising incidences of leukemia, lymphoma, and multiple...

The endonucleases market is experiencing robust growth as advancements in molecular biology, genetic engineering, and biotechnology continue to transform healthcare and life sciences research. Endonucleases are enzymes that cleave nucleic acid strands at specific internal sites, making them essential tools for DNA manipulation, gene editing, cloning, sequencing, and genome analysis. Their...

The epigenetic technologies market is witnessing remarkable growth as researchers and healthcare organizations increasingly focus on understanding gene regulation mechanisms and their impact on disease development. Epigenetics has emerged as a critical area of life science research, offering insights into how environmental factors and cellular processes influence gene expression without...

According to a new report from Intel Market Research, the Europe BFS (Blow‑Fill‑Seal) Products market was valued at USD 2.01 billion in 2024 and is projected to grow from USD 2.24 billion in 2025 to USD 4.37 billion by 2032, exhibiting a robust CAGR of 11.5% during the forecast period (2025–2032). This expansion is driven by the continent’s mature pharmaceutical ecosystem, stringent...

According to a newly published market research report by 24LifeSciences, global gene therapy for ovarian cancer market was valued at USD 423.7 million in 2024 and is projected to reach USD 1.12 billion by 2031, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 2025-2031. Gene therapy represents a revolutionary treatment paradigm for ovarian cancer, leveraging...

According to a newly published market research report by 24LifeSciences, global lentiviral packaging kit market was valued at USD 345.2 million in 2024 and is projected to reach USD 752.8 million by 2032, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period 2025-2032. Lentiviral packaging kits contain essential components to produce lentiviral vectors derived...

According to a newly published market research report by 24LifeSciences, global stem cell therapy for diabetes and related conditions market was valued at USD 456 million in 2024 and is projected to reach USD 892 million by 2031, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 2025–2031. Stem cell therapy...

According to a newly published market research report by 24LifeSciences, global thalassemia market was valued at USD 3.24 billion in 2024 and is projected to reach USD 5.92 billion by 2031, growing at a compound annual growth rate (CAGR) of 9.2% during the forecast period 20252031. Thalassemia, an inherited blood disorder characterized by abnormal hemoglobin production, leads to excessive...